Connect with us

Hi, what are you looking for?


Duterte’s health chief stands by controversial pandemic fund transfer


OUTGOING Health Secretary Francisco T. Duque III on Monday stood by a decision to pass on coronavirus response funds to the Budget department’s procurement service at the start of the pandemic, a transfer that became controversial due to questionable supply contracts awarded to a company owned by personalities with links to the President.  

“No regrets,” Mr. Duque told ABS-CBN News Channel. “There’s no evidence of wrongdoing.”  

The deals with Pharmally Pharmaceutical Corp. were the subject of a Senate committee investigation, but the final report that implicated President Rodrigo R. Duterte did not get majority support from the chamber.   

“I would not have done that differently,” Mr. Duque said. “I trusted the institution. I did not trust personalities,” said Mr. Duque, who had faced resignation calls over his handling of the pandemic response.   

The Senate last week released the top executives of Pharmally Pharmaceutical  who were detained for months after being cited in contempt for failing to provide documents relating to their supply contracts with the government.   

A Senate committee responsible for probing graft and corruption began its investigation into the government’s pandemic transactions after state auditors found deficiencies in the Health department’s handling of COVID-19 funds.  

In hearings, senators had repeatedly questioned the Health department for transferring about P42 billion to the procurement service agency under the Budget department for the purchase of pandemic supplies. Pharmally secured more than P8.6 billion worth of contracts in 2020.  

Senator Franklin M. Drilon, one of the senators who backed the inquiry, said the outgoing health official “should hire a good lawyer” because he is a “principal by indispensable cooperation.” 

“The Procurement Service- Department of Budget and Management (PS-DBM) could not have committed the plunder without the P42 billion Health funds being illegally transferred, without any documentation, to PS-DBM,” he said in a statement.    

Another legislator, Senator Aquilino Martin “Koko” L. Pimentel III, said the committee’s 113-page report speaks for itself when asked to comment on Mr. Duque’s remarks. — Kyle Aristophere T. Atienza

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!


Editor’s Pick

Bowmark Capital, the private equity investor, has backed the buy-out of Cornwall Insight, a leading provider of research, data and analysis to the energy...

Editor’s Pick

Rising diesel prices could soon stop Britain’s fishing crews from setting sail as it becomes too costly to fish, boat captains warned this weekend....

Editor’s Pick

Fewer firms are at risk of failure compared with last year, but smaller companies are struggling to stay afloat after the end of pandemic...

Editor’s Pick

Big Issue Group has revealed its exciting new rebrand and ambitious five-year strategy, which will reflect the organisation’s response to the huge challenges faced...

Editor’s Pick

The UK economy is at significant risk of entering a “mild recession” next year as soaring inflation takes its toll, according to KPMG. GDP...

Financial Advisors

The introduction of aggressive climate objectives by global economies and growing prospects for reducing carbon emissions are driving the growth of the district heating...

You May Also Like


BW FILE PHOTO GROSS BORROWINGS by the National Government reached P2.6 trillion as of end-September as it continued to raise funds to respond to...


REUTERS By Luz Wendy T. Noble, Reporter The country’s foreign exchange buffers slightly increased as of end-October as the value of the central bank’s...


COVID-19 has had a significant impact on the mental health of Filipinos across different groups all over the archipelago. From frontline workers, parents balancing...

Financial Advisors

The healthcare ecosystem is one that has thrived on the cusp of scientific progress, benefitting enormously from the winds of change in the technological...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Respect Investment. All Rights Reserved.